Creative Medical Technology Holdings, Inc. Increase (Decrease) in Other Current Assets
Creative Medical Technology Holdings, Inc. (CELZ) reported Increase (Decrease) in Other Current Assets of -$68.34 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-07
- Creative Medical Technology Holdings, Inc. increase (decrease) in other current assets for the quarter ending 2026-06-30 was -$34.57K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other current assets for the quarter ending 2026-03-31 was -$33.77K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other current assets for the quarter ending 2025-06-30 was -$52.56K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other current assets for the quarter ending 2025-03-31 was -$52.56K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other current assets for fiscal 2025 was -$53.90K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other current assets for fiscal 2024 was -$84.54K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other current assets for fiscal 2023 was -$108.20K, a 132.00% decline from fiscal 2022.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other current assets for fiscal 2022 was $338.12K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|
| 2026-06-30 | -$34.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$68.34K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | -$33.77K 10-Q · filed 2026-05-08 | ||
| 2025-12-31 | -$53.90K 10-K · filed 2026-03-20 | ||
| 2025-06-30 | -$52.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$105.11K 10-Q · filed 2026-08-07 | |
| 2025-03-31 | -$52.56K 10-Q · filed 2026-05-08 | ||
| 2024-12-31 | -$84.54K 10-K · filed 2026-03-20 | ||
| 2023-12-31 | -$108.20K 10-K · filed 2025-03-14 | ||
| 2022-12-31 | $338.12K 10-K · filed 2024-03-22 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $64.96K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $64.96K 10-Q · filed 2022-05-13 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |